Clinical trial / 2017
In a randomized trial of patients with tinnitus, melatonin 3 mg daily reduced Tinnitus Handicap Inventory scores more effectively than sertraline 50 mg daily.
Seventy patients with tinnitus were randomly divided into two groups receiving either melatonin (3 mg once daily) or sertraline (50 mg once daily) for 3 months. Baseline mean THI scores were 45.02 ± 17.67 for melatonin and 44.85 ± 20.57 for sertraline (P = 0.23). After 3 months, THI scores decreased significantly in both groups to 30.29 ± 19.62 and 36.96 ± 25.03, respectively (P < 0.01 for both), with a significantly greater decline observed in the melatonin group (P = 0.02).
- Study type
- Randomized clinical trial
- Who was studied
- 70 patients with tinnitus
- What was measured
- Tinnitus Handicap Inventory (THI) questionnaire scores
THE PAPER
Comparison of Melatonin and Sertraline Therapies on Tinnitus: A Randomized Clinical Trial.
Abtahi SH, Hashemi SM, Mahmoodi M, Nilforoush MH. Int J Prev Med, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.